Status:
UNKNOWN
Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 4
Lead Sponsor:
Isala
Conditions:
Trapeziometacarpal Osteoarthritis
Thumb Carpometacarpal Osteoarthritis
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
Trapeziometacarpal osteoarthritis is a common cause of pain and loss of hand function in postmenopausal women. Many surgical treatments have been described and recent literature has show that the rela...
Eligibility Criteria
Inclusion
- Women
- 40 years of age or more
- Symptomatic trapeziometacarpal osteoarthritis
- Eaton \& Glickel stage 4
Exclusion
- An operation for trapeziometacarpal osteoarthritis on the same hand in the past.
- Participation in randomized clinical trial for trapeziometacarpal osteoarthritis with contralateral hand.
- Secondary trapeziometacarpal osteoarthritis as result of trauma, rheumatoid arthritis, systemic lupus or gout.
- Symptomatic carpal tunnel syndrome in same hand.
- Symptomatic Quervain's tenosynovitis in same hand.
- Neurological or other disorders of the affected side that can influence postoperative rehabilitation.
- Insufficient knowledge of Dutch language.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT02204995
Start Date
September 1 2014
End Date
September 1 2021
Last Update
September 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isala Hospital
Zwolle, Overijssel, Netherlands